AAAAAA
Results: 301-325/1162
Authors:
Kwong, J
Xuan, JW
Choi, HL
Chan, PSF
Chan, FL
Citation: J. Kwong et al., PSP94 (or beta-microseminoprotein) is a secretory protein specifically expressed and synthesized in the lateral lobe of the rat prostate, PROSTATE, 42(3), 2000, pp. 219-229
Authors:
Wright, GL
Beckett, ML
Newhall, KR
Adam, BL
Cazares, LH
Cartwright, SL
Xiao, Z
Gong, L
Schellhammer, PF
Citation: Gl. Wright et al., Identification of a superimmunoglobulin gene family member overexpressed in benign prostatic hyperplasia, PROSTATE, 42(3), 2000, pp. 230-238
Authors:
Lou, W
Ni, ZY
Dyer, K
Tweardy, DJ
Gao, AC
Citation: W. Lou et al., Interleukin-6 induces prostate cancer cell growth accompanied by activation of Stat3 signaling pathway, PROSTATE, 42(3), 2000, pp. 239-242
Authors:
Grant, WB
Citation: Wb. Grant, Calcium, lycopene, vitamin D and prostate cancer, PROSTATE, 42(3), 2000, pp. 243-243
Authors:
Shin, M
Takayama, H
Nonomura, N
Wakatsuki, A
Okuyama, A
Aozasa, K
Citation: M. Shin et al., Extent and zonal distribution of prostatic intraepithelial neoplasia in patients with prostatic carcinoma in Japan: Analysis of whole-mounted prostatectomy specimens, PROSTATE, 42(2), 2000, pp. 81-87
Authors:
Spiotto, MT
Chung, TDK
Citation: Mt. Spiotto et Tdk. Chung, STAT3 mediates IL-6-induced growth inhibition in the human prostate cancercell line LNCaP, PROSTATE, 42(2), 2000, pp. 88-98
Authors:
El Etreby, MF
Liang, YY
Johnson, MH
Lewis, RW
Citation: Mf. El Etreby et al., Antitumor activity of mifepristone in the human LNCaP, LNCaP-C4, and LNCaP-C4-2 prostate cancer models in nude mice, PROSTATE, 42(2), 2000, pp. 99-106
Authors:
Schroder, FH
Kranse, R
Barbet, N
Hop, WCJ
Kandra, A
Lassus, M
Citation: Fh. Schroder et al., Prostate-specific antigen: A surrogate endpoint for screening new agents against prostate cancer?, PROSTATE, 42(2), 2000, pp. 107-115
Authors:
Xue, Y
van der Laak, J
Smedts, F
Schoots, C
Verhofstad, A
de la Rosette, J
Schalken, J
Citation: Y. Xue et al., Neuroendocrine cells during human prostate development: Does neuroendocrine cell density remain constant during fetal as well as postnatal life?, PROSTATE, 42(2), 2000, pp. 116-123
Authors:
Rogatsch, H
Mairinger, T
Horninger, W
Gschwendtner, A
Bartsch, G
Mikuz, G
Citation: H. Rogatsch et al., Optimized preembedding method improves the histologic yield of prostatic core needle biopsies, PROSTATE, 42(2), 2000, pp. 124-129
Authors:
Guo, YP
Sigman, DB
Borkowski, A
Kyprianou, N
Citation: Yp. Guo et al., Racial differences in prostate cancer growth: Apoptosis and cell proliferation in Caucasian and African-American patients, PROSTATE, 42(2), 2000, pp. 130-136
Authors:
Gkonos, PJ
Guo, F
Burnstein, KL
Citation: Pj. Gkonos et al., Type I vasoactive intestinal peptide receptor expression in PC3/AR cells is evidence of prostate epithelial differentiation, PROSTATE, 42(2), 2000, pp. 137-144
Authors:
Murphy, GP
Snow, PB
Brandt, J
Elgamal, A
Brawer, MK
Citation: Gp. Murphy et al., Evaluation of prostate cancer patients receiving multiple staging tests, including ProstaScint (R) scintiscans, PROSTATE, 42(2), 2000, pp. 145-149
Authors:
Djakiew, D
Citation: D. Djakiew, Dysregulated expression of growth factors and their receptors in the development of prostate cancer, PROSTATE, 42(2), 2000, pp. 150-160
Authors:
Chung, TDK
Yu, JJ
Kong, TA
Spiotto, MT
Lin, JM
Citation: Tdk. Chung et al., Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines, PROSTATE, 42(1), 2000, pp. 1-7
Authors:
Xie, W
Wong, YC
Tsao, SW
Wong, NS
Citation: W. Xie et al., Expression of a kallikrein-like protein in prostatic intraepithelial neoplasia in ventral prostate of the noble rat, PROSTATE, 42(1), 2000, pp. 8-17
Authors:
Still, K
Robson, CN
Autzen, P
Robinson, MC
Hamdy, FC
Citation: K. Still et al., Localization and quantification of mRNA for matrix metalloproteinase-2 (MMP-2) and tissue inhibitor of matrix metalloproteinase-2 (TIMP-2) in human benign and malignant prostatic tissue, PROSTATE, 42(1), 2000, pp. 18-25
Authors:
Strohmeyer, D
Rossing, C
Strauss, F
Bauerfeind, A
Kaufmann, O
Loening, S
Citation: D. Strohmeyer et al., Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer, PROSTATE, 42(1), 2000, pp. 26-33
Authors:
Jongsma, J
Oomen, MHA
Noordzij, MA
Romijn, JC
van der Kwast, TH
Schroder, FH
van Steenbrugge, GJ
Citation: J. Jongsma et al., Androgen-independent growth is induced by neuropeptides in human prostate cancer cell lines, PROSTATE, 42(1), 2000, pp. 34-44
Authors:
Shibata, Y
Ito, K
Suzuki, K
Nakano, K
Fukabori, Y
Suzuki, R
Kawabe, Y
Honma, S
Yamanaka, H
Citation: Y. Shibata et al., Changes in the endocrine environment of the human prostate transition zonewith aging: Simultaneous quantitative analysis of prostatic sex steroids and comparison with human prostatic histological composition, PROSTATE, 42(1), 2000, pp. 45-55
Authors:
Dennis, LK
Citation: Lk. Dennis, Meta-analysis for combining relative risks of alcohol consumption and prostate cancer, PROSTATE, 42(1), 2000, pp. 56-66
Authors:
Murphy, GP
Snow, P
Simmons, SJ
Tjoa, BA
Rogers, MK
Brandt, J
Healy, CG
Bolton, WE
Rodbold, D
Citation: Gp. Murphy et al., Use of artificial neural networks in evaluating prognostic factors determining the response to dendritic cells pulsed with PSMA peptides in prostate cancer patients, PROSTATE, 42(1), 2000, pp. 67-72
Authors:
Gupta, S
Srivastava, M
Ahmad, N
Bostwick, DG
Mukhtar, H
Citation: S. Gupta et al., Over-expression of cyclooxygenase-2 in Human prostate adenocarcinoma, PROSTATE, 42(1), 2000, pp. 73-78
Authors:
Schroder, FH
Citation: Fh. Schroder, Endocrine treatment of prostate cancer, PROSTATE, 2000, pp. 1-1
Authors:
van den Beld, AW
Lamberts, SWJ
Citation: Aw. Van Den Beld et Swj. Lamberts, The male climacterium: Clinical signs and symptoms of a changing endocrineenvironment, PROSTATE, 2000, pp. 2-8